Lisa D. Earnhardt

Innovation for All: Strategies for Maximizing Impact | Future of Health Summit 2024

Matthew Herper, Jay Bradner, Debi Brooks, Lisa D. Earnhardt, Elizabeth Fowler, Marc Samuels

This event synthesized breakthroughs in Parkinson's biomarker detection, the genetic discovery of obesity-protective alleles, and strategies to expand medical device access for underserved populations. Industry leaders and regulators discussed how these scientific advances confront systemic barriers in delivery and reimbursement, particularly regarding the high costs of gene therapies and the misalignment of current billing models with preventative care. The consensus emphasized that future progress depends on shifting focus from pure biological innovation to collaborative frameworks that ensure scalable manufacturing, equitable access, and payment reforms based on patient outcomes.